SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2018 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who wrote (167)8/17/2018 7:04:32 PM
From: BulbaMan  Read Replies (1) of 220
 
8/17/2018 Contest update
In my case and I imagine for most if not all in the Contest, investing in biotechs is more than just about making money. For me, this view was reinforced by the death of the “Queen of Soul,” Aretha Franklin, from pancreatic cancer and the recent diagnosis of a close friend with the more common but deadlier version of the disease. Unfortunately, as reported in the Forbes article linked below, progress in treating pancreatic cancer has been slow. Let’s hope there will be exceptional breakthroughs in the near future! forbes.com
Meanwhile, biotechs underperformed the broad market this week. At Friday’s close, the Contest median was up 8.74% YTD (vs. up 11.06% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 8.94% YTD (vs. up 9.56% YTD a week ago), the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 10.74% YTD (vs. up 12.16% YTD a week ago), while the Nasdaq Composite Index (IXIC) was up 13.22% YTD (vs. up 13.55% YTD a week ago).
KMASTR’s portfolio, up 82.11% YTD, gained another few percent and remained in first place with a large lead. ALIAS’s portfolio, up 63.90% YTD, and THID’s portfolio, up 50.47% YTD, held on to second and third place.
At Friday's close, 42 of the 62 Contest portfolios were in the green, with 31 beating the NBI and 29 beating the SPSIBI.
The 230 Contest stock picks have an average YTD gain of 4.09% and a median YTD loss of -7.63%, with 94 showing a gain for the year.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None
(All corrections, especially adjustments for splits & mergers, greatly appreciated.)
Enjoy a relaxing weekend biotechies!
Peace & good health,
Bulba

			8/17/18	
Rank Name Profit/Loss
1 KMASTR 82,111
2 ALIAS 63,898
3 THID 50,474
4 JBOG 48,044
5 ANDRE 46,652
6 MILJENKO44,402
7 TRONKA 39,773
8 MARKETH 39,579
9 AJM 38,599
10 USUBAN 38,451

Week's Top 5 Gainers
Symbol 8/10/18 8/17/18 Wk.%chg.
MGNK.DE 4.68 6.13 31.12%
RGLS 0.22 0.28 28.00%
BLPH 0.63 0.80 26.91%
GNMX 0.98 1.16 18.37%
NITE 16.80 19.88 18.33%

Week's Worst 5 Losers
Symbol 8/10/18 8/17/18 Wk.%chg.
CRMD 0.59 0.45 -23.20%
SNOA 2.30 1.77 -23.04%
AMDA 0.462 0.360 -22.10%
VTVT 1.26 1.00 -20.79%
CWBR 6.84 5.60 -18.13%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext